⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28230548 | 0.67 | — | — | |
| SCHEMBL27476655 | 0.67 | — | — | |
| SCHEMBL5539643 | 0.61 | — | — | |
| SCHEMBL28396653 | 0.61 | — | — | |
| SCHEMBL8679082 | 0.56 | — | — | |
| SCHEMBL7053562 | 0.56 | — | — | |
| SCHEMBL442087 | 0.56 | — | — | |
| SCHEMBL18261219 | 0.56 | — | — | |
| Chloromethane SCHEMBL17457033 | 0.56 | — | — | |
| SCHEMBL30059 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346612-A1 | INTRAMOLECULAR CYCLIZATION FOR GENERAL SYNTHESIS OF BICYCLIC ALKYL BIOISOSTERE BORONATES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250215019-A1 | ORTHOGONAL FUNCTIONALIZATION OF BRIDGE-SUBSTITUTED BCPS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-07-03 | — | — | US | disclosed |
| CN-119968374-A | Cephalotaxine derivatives, pharmaceutical composition, preparation method and application thereof | 南开大学 | 2025-05-09 | — | — | CN | disclosed |
| WO-2024061357-A1 | HARRINGTONINE DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF | 南开大学 | 2024-03-28 | — | — | WO | disclosed |
| WO-2023183757-A2 | ORTHOGONAL FUNCTIONALIZATION OF BRIDGE-SUBSTITUTED BCPS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-09-28 | — | — | WO | disclosed |
| US-20220389179-A1 | HYDROGEL LIQUID PRECURSOR, METHOD OF MANUFACTURING HYDROGEL FABRICATION PRODUCT, AND HYDROGEL FABRICATION PRODUCT | RICOH COMPANY, LTD. (JP) | 2022-12-08 | — | — | US | disclosed |
| EP-4065611-A1 | HYDROGEL LIQUID PRECURSOR, METHOD OF MANUFACTURING HYDROGEL FABRICATION PRODUCT, AND HYDROGEL FABRICATION PRODUCT | Ricoh Company, Ltd. (JP) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022170218-A1 | INTRAMOLECULAR CYCLIZATION FOR GENERAL SYNTHESIS OF BICYCLIC ALKYL BIOISOSTERE BORONATES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-08-11 | — | — | WO | disclosed |
| US-10988467-B2 | Compounds as ROR gamma modulators | GLENMARK PHARMACEUTICALS S.A. (CH) | 2021-04-27 | — | — | US | disclosed |
| EP-3686187-A1 | PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS | Glenmark Pharmaceuticals S.A. (CH) | 2020-07-29 | — | — | EP | disclosed |
| US-7625912-B2 | 2-Phenylpyrimidinone compounds; anticarcinogenic agents can be synergistically combined with one or more active ingredients such as paclitaxel or trastuzumab; side effect reduction | MERCK & CO. INC (US) | 2009-12-01 | — | — | US | disclosed |
| WO-2007146761-A2 | DIARYL PYRIMIDINONES AND RELATED COMPOUNDS | NEUROGEN CORPORATION (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070129356-A1 | Mitotic kinesin inhibitors | MERCK SHARP & DOHME CORP. | 2007-06-07 | — | — | US | disclosed |
| US-20070129356-A1 | Mitotic kinesin inhibitors | MERCK SHARP & DOHME CORP. | 2007-06-07 | — | — | US | disclosed |
| CN-1898215-A | Mitotic kinesin inhibitors | MERCK & CO INC (US) | 2007-01-17 | — | — | CN | disclosed |
| EP-1697331-A2 | MITOTIC KINESIN INHIBITORS | Merck & Co., Inc. (US) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005066175-A2 | CARBAPENEM INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION | GLAXO GROUP LIMITED (GB) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005060654-A2 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2005-07-07 | — | — | WO | disclosed |
| US-6310228-B1 | MONOVALENT COPPER IS COORDINATED WITH A BETA-DIKETONE COMPOUND AND AN UNSATURATED HYDROCARBON COMPOUND HAVING A SILYLOXY GROUP | MITSUBISHI MATERIALS CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| US-6040465-A | Process for producing optically active β-lactones | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2000-03-21 | — | — | US | disclosed |